Tumor-associated antigens as possible targets for immune therapy in head and neck cancer: comparative mRNA expression analysis of RAGE and GAGE genes
Specific immune therapy targeting residual areas of cancer cells may emerge as a powerful treatment strategy for head and neck squamous cell carcinoma (HNSCC). In order to define possible targets for immune therapy, we evaluated the frequency of two groups of tumor antigens - the RAGE and GAGE famil...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2002
|
| In: |
Acta oto-laryngologica
Year: 2002, Jahrgang: 122, Heft: 5, Pages: 546-552 |
| ISSN: | 1651-2251 |
| DOI: | 10.1080/00016480260092381 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1080/00016480260092381
|
| Verfasserangaben: | Karl Götte, Dirk Usener, Frank Riedel, Karl Hörmann, Dirk Schadendorf and Stefan Eichmüller |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1738930777 | ||
| 003 | DE-627 | ||
| 005 | 20220819025152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201117s2002 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/00016480260092381 |2 doi | |
| 035 | |a (DE-627)1738930777 | ||
| 035 | |a (DE-599)KXP1738930777 | ||
| 035 | |a (OCoLC)1341377740 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Götte, Karl |e VerfasserIn |0 (DE-588)140224920 |0 (DE-627)616951051 |0 (DE-576)315283424 |4 aut | |
| 245 | 1 | 0 | |a Tumor-associated antigens as possible targets for immune therapy in head and neck cancer |b comparative mRNA expression analysis of RAGE and GAGE genes |c Karl Götte, Dirk Usener, Frank Riedel, Karl Hörmann, Dirk Schadendorf and Stefan Eichmüller |
| 264 | 1 | |c 2002 | |
| 264 | 4 | |c 08 Jul 2009 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Elektronische Reproduktion der Druckausgabe | ||
| 500 | |a Gesehen am 17.11.2020 | ||
| 520 | |a Specific immune therapy targeting residual areas of cancer cells may emerge as a powerful treatment strategy for head and neck squamous cell carcinoma (HNSCC). In order to define possible targets for immune therapy, we evaluated the frequency of two groups of tumor antigens - the RAGE and GAGE families - by means of reverse transcriptase polymerase chain reaction using primary HNSCCs ( n =28), mucosa specimens as normal controls ( n =10) and HNSCC cell lines ( n =6). By means of specific primer selection we could differentiate between RAGE-1, -2, -3 and-4, as well as between two groups of GAGE genes (GAGE-1,2,7 vs GAGE-3,4,5,6,8). While all mucosa tissues (from smokers and non-smokers) were negative for both antigen families, 24/28 investigated tumors were positive for up to 5 tumor antigens. Among the RAGE genes, RAGE-1-positive tumors were the most abundant (8/28), followed by RAGE-2 (7/28) and RAGE-4 (6/28). Differences in the locations of HNSCCs were reflected by different RAGE family members being expressed most frequently: larynx, RAGE-1; oropharynx, RAGE-2; and hypopharynx, RAGE-4. Primers against GAGE-1,2,7 and GAGE-3,4,5,6,8 revealed 6/27 and 16/27 positive tumors, respectively. This report suggests that RAGE genes and GAGE-3,4,5,6,8 may be promising candidates for specific immune therapy in HNSCC. | ||
| 650 | 4 | |a Antigens | |
| 650 | 4 | |a Associated | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Gage | |
| 650 | 4 | |a Head | |
| 650 | 4 | |a Immune | |
| 650 | 4 | |a Neck | |
| 650 | 4 | |a Rage | |
| 650 | 4 | |a Specific | |
| 650 | 4 | |a Therapy | |
| 650 | 4 | |a Tumor | |
| 700 | 1 | |a Riedel, Frank |d 1971- |e VerfasserIn |0 (DE-588)120496747 |0 (DE-627)080711901 |0 (DE-576)29225010X |4 aut | |
| 700 | 1 | |a Hörmann, Karl |d 1948- |e VerfasserIn |0 (DE-588)130123749 |0 (DE-627)49171193X |0 (DE-576)266607438 |4 aut | |
| 700 | 1 | |a Schadendorf, Dirk |d 1960- |e VerfasserIn |0 (DE-588)11142576X |0 (DE-627)499566076 |0 (DE-576)289702275 |4 aut | |
| 700 | 1 | |a Eichmüller, Stefan B. |d 1960- |e VerfasserIn |0 (DE-588)1025289226 |0 (DE-627)721986951 |0 (DE-576)37016704X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta oto-laryngologica |d Stockholm : Taylor & Francis Group, 1918 |g 122(2002), 5, Seite 546-552 |h Online-Ressource |w (DE-627)301115621 |w (DE-600)1484331-6 |w (DE-576)079235484 |x 1651-2251 |7 nnas |a Tumor-associated antigens as possible targets for immune therapy in head and neck cancer comparative mRNA expression analysis of RAGE and GAGE genes |
| 773 | 1 | 8 | |g volume:122 |g year:2002 |g number:5 |g pages:546-552 |g extent:7 |a Tumor-associated antigens as possible targets for immune therapy in head and neck cancer comparative mRNA expression analysis of RAGE and GAGE genes |
| 856 | 4 | 0 | |u https://doi.org/10.1080/00016480260092381 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201117 | ||
| 993 | |a Article | ||
| 994 | |a 2002 | ||
| 998 | |g 1025289226 |a Eichmüller, Stefan B. |m 1025289226:Eichmüller, Stefan B. |d 60000 |e 60000PE1025289226 |k 0/60000/ |p 6 |y j | ||
| 998 | |g 11142576X |a Schadendorf, Dirk |m 11142576X:Schadendorf, Dirk |d 50000 |e 50000PS11142576X |k 0/50000/ |p 5 | ||
| 998 | |g 130123749 |a Hörmann, Karl |m 130123749:Hörmann, Karl |d 60000 |d 62100 |e 60000PH130123749 |e 62100PH130123749 |k 0/60000/ |k 1/60000/62100/ |p 4 | ||
| 998 | |g 120496747 |a Riedel, Frank |m 120496747:Riedel, Frank |d 60000 |e 60000PR120496747 |k 0/60000/ |p 3 | ||
| 999 | |a KXP-PPN1738930777 |e 3805805217 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"origin":[{"dateIssuedDisp":"2002","dateIssuedKey":"2002"}],"name":{"displayForm":["Karl Götte, Dirk Usener, Frank Riedel, Karl Hörmann, Dirk Schadendorf and Stefan Eichmüller"]},"recId":"1738930777","person":[{"role":"aut","given":"Karl","display":"Götte, Karl","family":"Götte"},{"family":"Riedel","display":"Riedel, Frank","given":"Frank","role":"aut"},{"family":"Hörmann","display":"Hörmann, Karl","given":"Karl","role":"aut"},{"role":"aut","family":"Schadendorf","given":"Dirk","display":"Schadendorf, Dirk"},{"role":"aut","display":"Eichmüller, Stefan B.","given":"Stefan B.","family":"Eichmüller"}],"title":[{"subtitle":"comparative mRNA expression analysis of RAGE and GAGE genes","title_sort":"Tumor-associated antigens as possible targets for immune therapy in head and neck cancer","title":"Tumor-associated antigens as possible targets for immune therapy in head and neck cancer"}],"language":["eng"],"id":{"doi":["10.1080/00016480260092381"],"eki":["1738930777"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"physDesc":[{"extent":"7 S."}],"note":["Elektronische Reproduktion der Druckausgabe","Gesehen am 17.11.2020"],"relHost":[{"pubHistory":["1.1918/19 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"301115621","disp":"Tumor-associated antigens as possible targets for immune therapy in head and neck cancer comparative mRNA expression analysis of RAGE and GAGE genesActa oto-laryngologica","language":["eng"],"id":{"zdb":["1484331-6"],"issn":["1651-2251"],"eki":["301115621"]},"part":{"text":"122(2002), 5, Seite 546-552","volume":"122","pages":"546-552","year":"2002","issue":"5","extent":"7"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 11.12.24"],"origin":[{"publisherPlace":"Stockholm ; Stockholm ; Oslo [u.a.]","dateIssuedKey":"1918","dateIssuedDisp":"1918-","publisher":"Taylor & Francis Group ; Informa Healthcare ; Scandinavian Univ. Pr."}],"title":[{"title_sort":"Acta oto-laryngologica","title":"Acta oto-laryngologica"}]}]} | ||
| SRT | |a GOETTEKARLTUMORASSOC2002 | ||